Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Jeffrey Keyser Insider Profile

4 Followers

Jeffrey Keyser, Director at Lantern Pharma, holds 94.30K shares in Lantern Pharma (Ticker: LTRN), holds 0.00 shares in ZS Pharma (Ticker: ZSPH). Most recently, Jeffrey Keyser Bought ― shares of Lantern Pharma on May 14, 2026 for an estimated value of $100.00K.

Jeffrey Keyser's Trading History

LTRNLantern Pharma		May 14, 2026DirectorInformative Buy100.00K$62.24K
ZSPHZS Pharma		Dec 21, 2015―Uninformative Sell1.11M$0.00
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Jeffrey Keyser insider profile FAQ

What is the percentage of profitable transactions made by Jeffrey Keyser?
The percentage of profitable transactions made by Jeffrey Keyser is 33%.
What is the average return per transaction made by Jeffrey Keyser?
The average return per transaction made by Jeffrey Keyser is -27.90%.
What stocks does Jeffrey Keyser hold?
Jeffrey Keyser holds: LTRN, ZSPH stocks.
What was Jeffrey Keyser’s latest transaction?
Jeffrey Keyser’s latest transaction was an Informative Buy of $100.00K.
What was Jeffrey Keyser's most profitable transaction?
Jeffrey Keyser’s most profitable transaction was an Informative Buy of LTRN stock on June 15, 2020. The return on the trade was 2.60%.
What is Jeffrey Keyser's role in Lantern Pharma?
Jeffrey Keyser's role in Lantern Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.